Overview

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Randomized controlled trial to determine clinical and microbiome difference between fractional CO2 Laser and vaginal estrogen in treating patients with recurrent urinary tract infection (UTI).
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estrogens
Estrogens, Conjugated (USP)
Polyestradiol phosphate